𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy—a pilot study

✍ Scribed by Judith D. Bauer; Sandra Capra


Publisher
Springer-Verlag
Year
2004
Tongue
English
Weight
115 KB
Volume
13
Category
Article
ISSN
0941-4355

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Pilot study of positron emission tomogra
✍ Dr. Salvatore U. Berlangieri; Dr. David M. Brizel; Dr. Richard L. Scher; Dr. Tob 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB

## Abstract __Background__. Positron emission tomography (PET) provides a noninvasive modality for evaluating the biochemical processes of normal and pathologic tissue. Preliminary reports of F‐18 fluorodeoxyglucose (FDG) PET indicate its potential usefulness in evaluating head and neck tumors. The

Nutritional intervention with fish oil p
✍ Rachel A. Murphy; Marina Mourtzakis; Quincy S.C. Chu; Vickie E. Baracos; Tony Re 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 3 views

## Abstract ## BACKGROUND: Involuntary weight loss is a major contributor to mortality and morbidity in patients with advanced cancer. Nutritional intervention with fish oil (FO)‐derived eicosapentaenoic acid (EPA) may prevent deterioration of body composition. This study compared intervention wit

Results of a pilot study of the effects
✍ Victor Lai; Jonathan George; Luther Richey; Hong J. Kim; Trinitia Cannon; Carol 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

## Abstract ## Background. Animal models suggest that cyclooxygenase‐2 (COX‐2) inhibitors may be beneficial in suppressing cancer cachexia. We investigated the effect of short‐course celecoxib on body composition, inflammation, and quality of life (QOL) in patients with cancer cachexia in a phase

Role of salvage chemotherapy with topote
✍ Ghamande, Sharad A.; Piver, M. Steven 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 2 views

## Background and Objectives: We assessed the role of salvage chemotherapy with topotecan and cisplatin in patients with platinum-and paclitaxel-resistant advanced and recurrent ovarian or primary peritoneal cancer, based on the reported in vivo and in vitro synergism between these two drugs. Meth